+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Microarray Biochips Market 2020-2024- Product Image

Global Microarray Biochips Market 2020-2024

  • ID: 5234891
  • Report
  • December 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • BioChain Institute Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corp.
  • General Electric Co.
  • MORE
Global Microarray Biochips Market 2020-2024

The publisher has been monitoring the microarray biochips market and it is poised to grow by $ 10.22 bn during 2020-2024 progressing at a CAGR of 20% during the forecast period. The report on microarray biochips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in market presence with collaboration strategy and growing use of personalized medicines. In addition, increase in market presence with collaboration strategy is anticipated to boost the growth of the market as well.

The microarray biochips market analysis includes application segment and geographical landscapes.

The microarray biochips market is segmented as below:

By Application
  • Drug discovery & development
  • Diagnostics & treatments
  • Research & consumables
  • Forensic medicines
  • Others
By Geographical Landscapes
  • North America
  • Europe
  • APAC
  • ROW
This study identifies rising demand of microarray biochips in genomics and proteomics as one of the prime reasons driving the microarray biochips market growth during the next few years.

The report on microarray biochips market covers the following areas:
  • Microarray biochips market sizing
  • Microarray biochips market forecast
  • Microarray biochips market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading microarray biochips market vendors that include Agilent Technologies Inc., BioChain Institute Inc., Bio-Rad Laboratories Inc., Cepheid Inc., Fluidigm Corp., General Electric Co., Illumina Inc., Merck KGaA, PerkinElmer Inc., and Thermo Fisher Scientific Inc.. Also, the microarray biochips market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • BioChain Institute Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corp.
  • General Electric Co.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Application
  • Market segments
  • Comparison by Application
  • Drug discovery and development - Market size and forecast 2019-2024
  • Diagnostics and treatments - Market size and forecast 2019-2024
  • Research and consumables - Market size and forecast 2019-2024
  • Forensic medicines - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Application
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor Landscape
  • Landscape disruption
  • Competitive Scenario
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • BioChain Institute Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corp.
  • General Electric Co.
  • Illumina Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
Exhibit
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2019 - 2024 ($ million)
  • Global market: Year-over-year growth 2019 - 2024 (%)
  • Five forces analysis 2019 & 2024
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2019
  • Application - Market share 2019-2024 (%)
  • Comparison by Application
  • Drug discovery and development - Market size and forecast 2019-2024 ($ million)
  • Drug discovery and development - Year-over-year growth 2019-2024 (%)
  • Diagnostics and treatments - Market size and forecast 2019-2024 ($ million)
  • Diagnostics and treatments - Year-over-year growth 2019-2024 (%)
  • Research and consumables - Market size and forecast 2019-2024 ($ million)
  • Research and consumables - Year-over-year growth 2019-2024 (%)
  • Forensic medicines - Market size and forecast 2019-2024 ($ million)
  • Forensic medicines - Year-over-year growth 2019-2024 (%)
  • Others - Market size and forecast 2019-2024 ($ million)
  • Others - Year-over-year growth 2019-2024 (%)
  • Market opportunity by Application
  • Customer landscape
  • Market share by geography 2019-2024 (%)
  • Geographic comparison
  • North America - Market size and forecast 2019-2024 ($ million)
  • North America - Year-over-year growth 2019-2024 (%)
  • Europe - Market size and forecast 2019-2024 ($ million)
  • Europe - Year-over-year growth 2019-2024 (%)
  • APAC - Market size and forecast 2019-2024 ($ million)
  • APAC - Year-over-year growth 2019-2024 (%)
  • ROW - Market size and forecast 2019-2024 ($ million)
  • ROW - Year-over-year growth 2019-2024 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Key customers
  • Agilent Technologies Inc. - Segment focus
  • BioChain Institute Inc. - Overview
  • BioChain Institute Inc. - Product and service
  • BioChain Institute Inc. - Key offerings
  • BioChain Institute Inc. - Key customers
  • BioChain Institute Inc. - Segment focus
  • Bio-Rad Laboratories Inc. - Overview
  • Bio-Rad Laboratories Inc. - Business segments
  • Bio-Rad Laboratories Inc. - Key offerings
  • Bio-Rad Laboratories Inc. - Key customers
  • Bio-Rad Laboratories Inc. - Segment focus
  • Cepheid Inc. - Overview
  • Cepheid Inc. - Product and service
  • Cepheid Inc. - Key offerings
  • Cepheid Inc. - Key customers
  • Cepheid Inc. - Segment focus
  • Fluidigm Corp. - Overview
  • Fluidigm Corp. - Business segments
  • Fluidigm Corp. - Key offerings
  • Fluidigm Corp. - Key customers
  • Fluidigm Corp. - Segment focus
  • General Electric Co. - Overview
  • General Electric Co. - Business segments
  • General Electric Co. - Key offerings
  • General Electric Co. - Key customers
  • General Electric Co. - Segment focus
  • Illumina Inc. - Overview
  • Illumina Inc. - Product and service
  • Illumina Inc. - Key offerings
  • Illumina Inc. - Key customers
  • Illumina Inc. - Segment focus
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key offerings
  • Merck KGaA - Key customers
  • Merck KGaA - Segment focus
  • PerkinElmer Inc. - Overview
  • PerkinElmer Inc. - Business segments
  • PerkinElmer Inc. - Key offerings
  • PerkinElmer Inc. - Key customers
  • PerkinElmer Inc. - Segment focus
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Key customers
  • Thermo Fisher Scientific Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • BioChain Institute Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corp.
  • General Electric Co.
  • MORE
The publisher recognizes the following companies as the key players in the global microarray biochips market: Agilent Technologies Inc., BioChain Institute Inc., Bio-Rad Laboratories Inc., Cepheid Inc., Fluidigm Corp., General Electric Co., Illumina Inc., Merck KGaA, PerkinElmer Inc., and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising demand of microarray biochips in genomics and proteomics.'

According to the report, one of the major drivers for this market is the increase in market presence with collaboration strategy.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • Agilent Technologies Inc.
  • BioChain Institute Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corp.
  • General Electric Co.
  • Illumina Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll